Sign in

CIK 0001590750

  • Large accelerated filer

Viridian Therapeutics, Inc.DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471187261
Phone
+1 617-272-4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-26 Harwin Peter Evan Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2023-06-14 Harwin Peter Evan Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2022-06-08 Harwin Peter Evan Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2021-06-03 Harwin Peter Evan Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2021-02-04 Harwin Peter Evan Director Grant or award · Director Stock Option (Right to Buy) +25,000 25,000
2020-10-27 Harwin Peter Evan Director Grant or award · Director Stock Option (Right to Buy) +24,000 24,000

Page 1 of 1 · 6 trades